TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ... Nature 554 (7693), 544-548, 2018 | 3737 | 2018 |
Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression S Lianoglou, V Garg, JL Yang, CS Leslie, C Mayr Genes & Development 27 (21), 2380-2396, 2013 | 457 | 2013 |
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge AA Nugent, K Lin, B Van Lengerich, S Lianoglou, L Przybyla, SS Davis, ... Neuron 105 (5), 837-854. e9, 2020 | 428 | 2020 |
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice J Lau, J Cheung, A Navarro, S Lianoglou, B Haley, K Totpal, L Sanders, ... Nature communications 8 (1), 14572, 2017 | 352 | 2017 |
Reproducible pharmacogenomic profiling of cancer cell line panels PM Haverty, E Lin, J Tan, Y Yu, B Lam, S Lianoglou, RM Neve, S Martin, ... Nature 533 (7603), 333-337, 2016 | 291 | 2016 |
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity Y Kong, CM Rose, AA Cass, AG Williams, M Darwish, S Lianoglou, ... Nature communications 10 (1), 5228, 2019 | 190 | 2019 |
Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs SM Park, RP Deering, Y Lu, P Tivnan, S Lianoglou, F Al-Shahrour, ... Journal of Experimental Medicine 211 (1), 71-87, 2014 | 162 | 2014 |
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice JC Ullman, A Arguello, JA Getz, A Bhalla, CS Mahon, J Wang, T Giese, ... Science Translational Medicine 12 (545), eaay1163, 2020 | 143 | 2020 |
Genome-wide identification of miRNA targets by PAR-CLIP M Hafner, S Lianoglou, T Tuschl, D Betel Methods 58 (2), 94-105, 2012 | 121 | 2012 |
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration YW Lim, H Chen-Harris, O Mayba, S Lianoglou, A Wuster, T Bhangale, ... Proceedings of the National Academy of Sciences 115 (50), E11701-E11710, 2018 | 112 | 2018 |
Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1–TFE3 fusion oncoprotein R Kobos, M Nagai, M Tsuda, MY Merl, T Saito, M Laé, Q Mo, A Olshen, ... The Journal of Pathology, 2013 | 86 | 2013 |
Testosterone is an endogenous regulator of BAFF and splenic B cell number AS Wilhelmson, M Lantero Rodriguez, A Stubelius, P Fogelstrand, ... Nature communications 9 (1), 2067, 2018 | 76 | 2018 |
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models B van Lengerich, L Zhan, D Xia, D Chan, D Joy, JI Park, D Tatarakis, ... Nature neuroscience 26 (3), 416-429, 2023 | 72 | 2023 |
The immunoglobulin superfamily receptome defines cancer-relevant networks associated with clinical outcome E Verschueren, B Husain, K Yuen, Y Sun, S Paduchuri, Y Senbabaoglu, ... Cell 182 (2), 329-344. e19, 2020 | 68 | 2020 |
A predictive model of the oxygen and heme regulatory network in yeast A Kundaje, X Xin, C Lan, S Lianoglou, M Zhou, L Zhang, C Leslie PLoS computational biology 4 (11), e1000224, 2008 | 55 | 2008 |
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia D Xia, S Lianoglou, T Sandmann, M Calvert, JH Suh, E Thomsen, ... Molecular neurodegeneration 17 (1), 41, 2022 | 36 | 2022 |
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes TL Arenzana, S Lianoglou, A Seki, C Eidenschenk, T Cheung, ... Science immunology 3 (22), eaal1953, 2018 | 31 | 2018 |
Learning regulatory programs that accurately predict differential expression with MEDUSA A Kundaje, S Lianoglou, X Li, D Quigley, M Arias, CH Wiggins, L Zhang, ... Annals of the New York Academy of Sciences 1115 (1), 178-202, 2007 | 19 | 2007 |
Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock-in mouse model D Xia, S Lianoglou, T Sandmann, M Calvert, JH Suh, E Thomsen, ... bioRxiv, 2021.01. 19.426731, 2021 | 8 | 2021 |
Methods of treating cancer using pd-1 axis binding antagonist and il-17 binding antagonists J Grogan, X Yuanyuan, P Caplazi, S Lianoglou, J Hackney, EY Chiang | 6 | 2016 |